Literature DB >> 9889257

Localization and expression of tissue kallikrein and kallistatin in human blood vessels.

W C Wolf1, R A Harley, D Sluce, L Chao, J Chao.   

Abstract

Tissue kallikrein releases kinins by specific proteolysis, an activity inhibited by kallistatin. In this study, kallikrein and kallistatin were localized to endothelial and smooth muscle cells of large, medium, and small normal blood vessels by immunohistochemical techniques. Immunostaining for both proteins was strong in the endothelium of all sizes of blood vessels and was more intense in medial smooth muscle cells of small and medium-sized blood vessels than in elastic arteries. The sites of synthesis by endothelial and smooth muscle cells were demonstrated in normal blood vessels of all sizes by in situ hybridization histochemistry. Kallikrein and kallistatin levels were measured by immunoassays in homogenates of human aorta, vena cava, and iliac artery and vein. Tissue kallikrein and kallistatin transcripts were identified in human blood vessels by RT-PCR followed by Southern blot analysis with specific oligonucleotide probes. The results demonstrated the expression and co-localization of tissue kallikrein and kallistatin in human vessels and suggest a potential role of kallistatin in regulating tissue kallikrein in blood vessels.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9889257     DOI: 10.1177/002215549904700210

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  28 in total

1.  Endothelial AT(2)-receptors: chicken or egg?

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 2.  Protective Role of Kallistatin in Vascular and Organ Injury.

Authors:  Julie Chao; Grant Bledsoe; Lee Chao
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

Review 3.  Angiogenesis in diabetes and obesity.

Authors:  Rui Cheng; Jian-xing Ma
Journal:  Rev Endocr Metab Disord       Date:  2015-03       Impact factor: 6.514

4.  Delivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in rats.

Authors:  Ling Tu; Xizhen Xu; Huaibing Wan; Changqing Zhou; Juanjuan Deng; Gang Xu; Xiao Xiao; Yipu Chen; Matthew L Edin; James W Voltz; Darryl C Zeldin; Dao Wen Wang
Journal:  Hum Gene Ther       Date:  2008-04       Impact factor: 5.695

5.  Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.

Authors:  Youming Guo; Pengfei Li; Grant Bledsoe; Zhi-Rong Yang; Lee Chao; Julie Chao
Journal:  Exp Cell Res       Date:  2015-07-05       Impact factor: 3.905

Review 6.  Kallikrein-kinin in stem cell therapy.

Authors:  Julie Chao; Grant Bledsoe; Lee Chao
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

7.  Aortic implantation of mesenchymal stem cells after aneurysm injury in a porcine model.

Authors:  Irene C Turnbull; Lahouaria Hadri; Kleopatra Rapti; Mikel Sadek; Lifan Liang; Hyun J Shin; Kevin D Costa; Michael L Marin; Roger J Hajjar; Peter L Faries
Journal:  J Surg Res       Date:  2011-07-13       Impact factor: 2.192

8.  Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.

Authors:  Sigurdur T Sigurdsson; Olaf B Paulson; Arne Høj Nielsen; Svend Strandgaard
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

9.  Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress.

Authors:  Bo Shen; Lee Chao; Julie Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-15       Impact factor: 4.733

10.  Increased serum kallistatin levels in type 1 diabetes patients with vascular complications.

Authors:  Alicia J Jenkins; Jeffrey D McBride; Andrzej S Januszewski; Connie S Karschimkus; Bin Zhang; David N O'Neal; Craig L Nelson; Jasmine S Chung; C Alex Harper; Timothy J Lyons; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.